Similarly, miR-26a-5p, which can promote proliferation and migration of osteosarcoma by targeting HOXA5 acting as a tumor oncogene for osteosarcoma, could be exploited in the future as part of specific therapies for this disease [35]. The gene discussed is HOXA5; the disease is osteosarcoma.